Manufacturer Doesn’t Expect Zika Blood-Screening Test Shortage
Executive Summary
US FDA has asked Miami-area blood banks to close until they can screen all blood supplies for the Zika virus in the wake of the first known cases transmitted by mosquitos within the US. A manufacturer of the only test currently available for blood-bank use does not expect shortages, despite the increased demand.
You may also be interested in...
Hologic/Grifols, Roche Molecular Zika Tests Tapped For Blood-Screening Ramp-Up
A blood-screening test made by Hologic in collaboration with Grifols, and another made by Roche Molecular Diagnostics, are being used in a gradual ramp-up of Zika virus screening at blood donation centers across the US under a new FDA program.
FDA Clears Another Zika Assay, Luminex's xMap
The xMap Multiflex Zika RNA Assay is a molecular diagnostic that is designed to detect the Zika virus in human serum, urine or plasma.
House-Senate Conferees Fight Over Zika Funds As FDA Approves More Assays
Emergency funding to battle the summer's mosquito-borne Zika threat is trapped in a military/VA spending bill. Conferees must find a compromise between the House's $622m bid and the Senate's $1.1b offer in the thin stretch of time when both chambers will be session before they adjourn on July 15. In the interim, FDA has authorized more Zika tests.